Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Go back to Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 172.94 +18.90 (12.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.04 | 52 Week High | $0.52 | |||
| Open | $161.05 | 52 Week Low | $0.08 | |||
| Day High | $176.86 | P/E | N/A | |||
| Day Low | $159.06 | EPS | $-3.80 | |||
| Volume | 20,980,577 | |||||
